In July 2022, Mylab Discovery Solutions launched a comprehensive multiplex RT-PCR test kit for all monsoon diseases including malaria, chikungunya, dengue, Zika, leptospirosis, salmonellosis species and leishmaniasis. "PathoDetect Extended Monsoon Thermal Panel" has been released Parasite.
In April 2022, as the monsoon period increases the risk of leptospirosis, India's Ministry of Health launched the 'Mritiunjayam' campaign in Kerela to raise awareness about the disease.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5469
Published Date: Dec 22, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing expansion of the pet population and high prevalence of leptospirosis are some of the major factors anticipated to drive the growth of the canine leptospirosis market.
The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2024-2036
The major players in the market are of Baxter International Inc., Zoetic Pharmaceuticals Private Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceuticals Industries Ltd, Aurobindo Pharma, King Pharmaceuticals, and others.
The veterinary hospital pharmacies segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.